drugset / Trial / NCT04032392
Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT Cells
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the safety, tolerability and efficacy of autologous γδT cells in the treatment of advanced hepatitis B-related hepatocellular carcinoma.
Timeline
- Start
- 2019-07-23
- Primary completion
- 2021-07-30
- Completion
- 2022-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous γδT cells | Cell therapy | 1e+09 cells | Intravenous |
| Subject | Autologous γδT cells | Cell therapy | 2e+09 cells | Intravenous |
| Subject | Autologous γδT cells | Cell therapy | 6e+09 cells | Intravenous |